 HOLON, Israel, Feb. 25, 2021 PRNewswire -- Compugen Ltd. NASDAQ: CGEN, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the fourth quarter and full year ended December 31, 2020. Our encouraging new data... 